Kefiran as a Novel Biomaterial Ink Component: Preliminary Assessment of 3D Printing Feasibility and Biocompatibility

The development of biomimetic scaffolds requires balancing structural integrity with biological signaling. This study evaluates kefiran, a microbial exopolysaccharide, as a bioactive component in establishing printing feasibility of 3D composite constructs. Kefiran from Romanian artisanal cultures was characterized via ¹H-NMR, HPLC, and SEM/TEM, confirming a high-quality hexasaccharide repeating unit. Three composite inks (K100, K70, and K50) were developed by integrating kefiran, chondroitin sulfate, and Si-substituted hydroxyapatite into an alginate matrix and processed using a Bio X 3D-printer. Results showed that higher kefiran concentrations improved printing feasibility, providing enhanced structural fidelity and stability during the layer-by-layer deposition process. All bioprinted scaffolds demonstrated high cytocompatibility with L929 fibroblasts, maintaining viability above 70%. Notably, kefiran exhibited dual-functional therapeutic potential: concentrations above 500 mg/L showed a concentration-dependent antiproliferative effect against HT-29 cells at 72 h while remaining safe for normal cells. These findings establish kefiran-based biomaterial inks as robust, bioactive platforms for regenerative medicine. By enhancing both the mechanical printability of alginate composites and the biological response of cultured cells, kefiran proves to be a versatile component for advanced tissue engineering and potential biological activity applications.